Results 121 to 130 of about 60,497 (244)

Lymphocytic Esophagitis Mimicking Eosinophilic Esophagitis and Esophageal Candidiasis: A Case Report

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT A 59‐year‐old man presented with a 5‐year history of progressive dysphagia. Esophagogastroduodenoscopy (EGD) revealed an esophageal stricture with adherent whitish exudates, and biopsy specimens demonstrated fungal elements. Subsequent EGD showed longitudinal furrows, concentric rings, and white exudates, mimicking eosinophilic esophagitis ...
Hiroshi Sugawara, Makoto Eizuka, Yosuke Toya, Ryo Sugimoto, Shunichi Yanai, Yuki Yasumi, Naoki Yanagawa, Takayuki Matsumoto   +7 more
wiley   +1 more source

Severe Congenital Candidiasis due to <i>Candida dubliniensis</i> Treated With Fosfluconazole in a Preterm Infant. [PDF]

Case Rep Pediatr
Higashiyama H, Futatani T.
europepmc   +1 more source

Hepatosplenic Candidiasis [PDF]

Clinical Infectious Diseases, 2016
openaire   +2 more sources

Systemic Candidiasis [PDF]

RadioGraphics, 2003
Nicholas J E, Moore, Johnsey L, Leef, Yijun, Pang   +2 more
openaire   +2 more sources

A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B‐Cell Lymphoma

American Journal of Hematology, Volume 101, Issue 9, Page 2177-2189, September 2026.
ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez, Mariana Bastos‐Oreiro, Catherine Diefenbach, Izidore S. Lossos, Nirav Shah, Sarit Assouline, Adam J. Olszewski, Seema Naik, Nilanjan Ghosh, Song Pham, Michael C. Wei, Connie Batlevi, Iris To, Wahib Ead, Sneha Makadia, Elicia Penuel, Jing Jing, Lihua E. Budde   +17 more
wiley   +1 more source

Hepatic Candidiasis Following Drug-Induced Neutropenia in ANCA-Associated Vasculitis: A Diagnostic Challenge. [PDF]

ACG Case Rep J
Park JH, Kumar R, Vikash F, Kumar S, Nankani A, Kajal D, Radulovic M, Patel S.   +7 more
europepmc   +1 more source

Ruxolitinib Pharmacokinetics and Exposure–Toxicity Relationship in Hematologic Malignancies and Immune‐Mediated Diseases: A Prospective Observational Study

Clinical Pharmacology &Therapeutics, Volume 120, Issue 3, Page 753-761, September 2026.
Ruxolitinib pharmacokinetics (PK) has been characterized in clinical trials but remains poorly documented in real‐world practice. This project aimed to investigate ruxolitinib PK in routine clinical practice, identify factors driving its variability, and explore exposure–response relationships to assess the potential role of therapeutic drug monitoring.
Jérémie Tachet, Sara C. Meyer, Francesco Grandoni, Emmanuel Haefliger, Monika Nagy‐Hulliger, Jörg P. Halter, Jakob R. Passweg, David Haefliger, Carine Bardinet, Laurent A. Decosterd, Monia Guidi, François R. Girardin   +11 more
wiley   +1 more source

Prevalence of Oral Fungal Infections Among Hemodialysis Patients and Their Association With Clinical and Demographic Factors: A Retrospective Study. [PDF]

Cureus
Al Momani AM, Al Hammad L, Al Majali N, Al Zgoul B, Hamed A, Khuluqi A.   +5 more
europepmc   +1 more source

Increased Risk of Environmental and Endemic Infectious Diseases in Sjögren's Disease: A Retrospective Analysis (2015–2023)

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective Sjögren's disease (SjD) is a chronic autoimmune disease with a complex etiology, where pathogens may influence disease development or progression. Although SjD is not communicable, environmental and endemic pathogen exposures may influence its onset or progression.
Swetha K. Shankar, Taylor C. Boone, Eliza C. Diggins, Melodie L. Weller   +3 more
wiley   +1 more source

The Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis. [PDF]

Infect Drug Resist
Zubovskaia A, Vazquez JA.
europepmc   +1 more source